Clinical Trial Update: AL-15469A for the Treatment of Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

The update indicates that a Phase 3 trial evaluating AL-15469A for bacterial conjunctivitis has completed. No trial results are disclosed in this excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• AL-15469A

Snippet

Sponsor: Alcon Research | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED